PubMed · 2023

Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.

Kosiborod MN, Abildstrøm SZ, Borlaug BA, Butler J, et al. (2023). Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.. N Engl J Med.

N Engl J Med

View original source
XRedditFacebook

This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.